Tango Therapeutics's total assets for Q3 2025 were $210.14M, a decrease of -11.67% from the previous quarter. TNGX total liabilities were $50.10M for the fiscal quarter, a -51.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.